# Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension

> **NCT05678621** · PHASE2,PHASE3 · RECRUITING · sponsor: **Monash University** · enrollment: 300 (estimated)

## Conditions studied

- Haematological Malignancy
- Hypogammaglobulinemia

## Interventions

- **DRUG:** trimethoprim-sulfamethoxazole (co-trimoxazole)
- **DRUG:** amoxycillin/clavulanic acid and ciprofloxacin
- **DRUG:** Immunoglobulins

## Key facts

- **NCT ID:** NCT05678621
- **Lead sponsor:** Monash University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-30
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05678621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05678621, "Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05678621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*